ArticleTranslational lung cancer research2020

Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323.

Toshiyuki Kozuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.